Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 360,992 | 285,350 | 405,189 | 307,811 | 464,964 |
| General And Administrative Expense | 360,992 | 285,350 | 405,189 | 307,811 | 464,964 |
| Other Operating Expenses | 4,799 | 21,459 | 100,460 | 16,041 | 14,484 |
| Operating Expense | 365,791 | 306,809 | 505,649 | 323,852 | 479,448 |
| Operating Income | -365,791 | -306,809 | -505,649 | -323,852 | -479,448 |
| EBIT | -365,791 | -306,809 | -505,649 | -323,852 | -479,448 |
| Interest Income | 70,742 | 81,122 | 233,324 | 77,161 | 93,127 |
| Interest Income Non Operating | 70,742 | 81,122 | 233,324 | 77,161 | 93,127 |
| Net Interest Income | 70,742 | 81,122 | 233,324 | 77,161 | 93,127 |
| Other Income Expense | 18.8M | 1.7M | -1.2M | -5.6M | -362,949 |
| Gain On Sale Of Security | 18.8M | 1.7M | -1.2M | -5.6M | -340,578 |
| Earnings From Equity Interest | -- | 0.00 | 0.00 | 0.00 | -22,371 |
| Pretax Income | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Tax Effect Of Unusual Items | 2.8M | 247,664 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Net Income From Continuing Operation Net Minority Interest | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Net Income Including Noncontrolling Interests | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Minority Interests | -- | -- | -- | -- | 0.00 |
| Net Income Common Stockholders | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Net Income | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| EBITDA | -365,791 | -306,809 | -505,649 | -323,852 | -479,448 |
| Normalized EBITDA | -19.1M | -2.0M | 709,622 | 5.3M | -138,870 |
| Reconciled Depreciation | -- | 0.00 | -- | -- | 0.00 |
| Basic EPS | 0.11 | 0.01 | -0.01 | -0.04 | -- |
| Diluted EPS | 0.11 | 0.01 | -0.01 | -0.04 | -- |
| Basic Average Shares | 169.3M | 165.2M | 141.3M | 141.3M | -- |
| Diluted Average Shares | 173.1M | 165.2M | 141.3M | 141.3M | -- |
| Total Unusual Items | 18.8M | 1.7M | -1.2M | -5.6M | -340,578 |
| Total Unusual Items Excluding Goodwill | 18.8M | 1.7M | -1.2M | -5.6M | -340,578 |
| Tax Rate For Calcs | 0.15 | 0.15 | 0.00 | 0.00 | 0.00 |
| Normalized Income | 2.5M | 21,977 | -272,325 | -246,691 | -408,692 |
| Diluted NI Availto Com Stockholders | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Net Income Continuous Operations | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Net Income Discontinuous Operations | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Non Operating Interest Income Expense | 70,742 | 81,122 | 233,324 | 77,161 | 93,127 |
| Other Gand A | 120,511 | 97,832 | 209,173 | 116,113 | 275,269 |
| Salaries And Wages | 240,481 | 187,518 | 196,016 | 191,698 | 189,695 |
| Total Expenses | 365,791 | 306,809 | 505,649 | 323,852 | 479,448 |
| Total Operating Income As Reported | -- | -- | -445,742 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 3.2M | 4.2M | 3.0M | 5.1M | 5.5M |
| Cash Cash Equivalents And Short Term Investments | 3.2M | 4.2M | 3.0M | 5.1M | 5.5M |
| Cash Financial | 3.2M | 4.2M | 3.0M | 5.1M | 5.5M |
| Receivables | 1.5M | 1.3M | 1.2M | 426,539 | 337,610 |
| Current Assets | 4.7M | 5.4M | 4.2M | 5.6M | 5.8M |
| Gross PPE | -- | -- | -- | -- | 10.3M |
| Accumulated Depreciation | -- | -- | -- | -- | -10.3M |
| Net PPE | -- | -- | -- | -- | 0.00 |
| Investments And Advances | 48.3M | 28.1M | 26.4M | 26.6M | 32.2M |
| Long Term Equity Investment | -- | -- | -- | -- | 0.00 |
| Other Investments | 48.3M | 28.1M | 26.4M | 26.6M | 32.2M |
| Total Non Current Assets | 48.3M | 28.1M | 26.4M | 26.6M | 32.2M |
| Total Assets | 53.0M | 33.5M | 30.6M | 32.1M | 38.0M |
| Accounts Payable | -- | -- | -- | -- | 66,398 |
| Payables | -- | -- | -- | -- | 66,396 |
| Payables And Accrued Expenses | 149,560 | 102,010 | 74,031 | 79,082 | 110,896 |
| Current Accrued Expenses | -- | -- | -- | -- | 44,500 |
| Current Liabilities | 149,560 | 102,010 | 74,031 | 79,082 | 110,896 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 149,560 | 102,010 | 74,031 | 79,082 | 110,896 |
| Common Stock | 111.2M | 111.7M | 110.3M | 110.3M | 110.3M |
| Capital Stock | 111.2M | 111.7M | 110.3M | 110.3M | 110.3M |
| Retained Earnings | -73.2M | -92.7M | -94.2M | -92.7M | -86.8M |
| Gains Losses Not Affecting Retained Earnings | -- | -- | -- | -- | 14.4M |
| Common Stock Equity | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Stockholders Equity | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Total Equity Gross Minority Interest | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Minority Interest | -- | -- | -- | -- | 0.00 |
| Total Capitalization | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Net Tangible Assets | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Tangible Book Value | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Working Capital | 4.6M | 5.3M | 4.2M | 5.5M | 5.7M |
| Invested Capital | 52.9M | 33.4M | 30.6M | 32.1M | 37.9M |
| Share Issued | 169.3M | 169.3M | 141.3M | 141.3M | 141.3M |
| Ordinary Shares Number | 169.3M | 169.3M | 141.3M | 141.3M | 141.3M |
| Construction In Progress | -- | -- | -- | -- | 0.00 |
| Investmentsin Associatesat Cost | -- | -- | -- | -- | 0.00 |
| Machinery Furniture Equipment | -- | -- | -- | -- | 218,593 |
| Notes Receivable | 1.1M | 989,097 | 915,774 | -- | -- |
| Other Equity Interest | 14.9M | 14.4M | 14.4M | 14.4M | -- |
| Other Properties | -- | -- | -- | -- | 10.1M |
| Other Receivables | 246,330 | 129,268 | 151,336 | 276,083 | 179,316 |
| Taxes Receivable | 161,212 | 151,556 | 148,729 | 150,456 | 158,294 |
| Line Item | Q3 2025Sep 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -390,984 | -201,166 | -117,719 | -365,425 | -163,947 |
| Cash Flow From Continuing Operating Activities | -390,984 | -201,166 | -117,719 | -365,425 | -163,947 |
| Depreciation And Amortization | -- | 0.00 | -- | -- | 0.00 |
| Depreciation Amortization Depletion | -- | 0.00 | -- | -- | 0.00 |
| Stock Based Compensation | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Working Capital | -103,253 | 47,220 | 121,423 | -120,743 | 174,374 |
| Change In Receivables | 6,124 | -2,827 | 1,727 | 7,838 | 94,395 |
| Change In Payables And Accrued Expense | -87,901 | 27,979 | -5,051 | -31,814 | 36,694 |
| Change In Other Current Assets | -- | -- | -- | -- | 0.00 |
| Other Non Cash Items | -- | -50,963 | -5.5M | 5.5M | -- |
| Net PPE Purchase And Sale | -- | 0.00 | -- | -- | -48,001 |
| Purchase Of Business | -- | -- | -- | -- | 0.00 |
| Purchase Of Investment | -- | -60,000 | -- | -- | -- |
| Net Investment Purchase And Sale | -- | -60,000 | -- | -- | -- |
| Investing Cash Flow | -- | -60,000 | -2.0M | 0.00 | -1.0M |
| Cash Flow From Continuing Investing Activities | -- | -60,000 | -- | -- | -1.0M |
| Issuance Of Capital Stock | -- | -- | -- | -- | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | -- | 0.00 |
| Financing Cash Flow | -- | -- | -- | -- | 0.00 |
| Cash Flow From Continuing Financing Activities | -- | -- | -- | -- | 0.00 |
| Changes In Cash | -390,984 | 1.1M | -2.1M | -365,425 | -1.2M |
| Beginning Cash Position | 3.6M | 3.0M | 5.1M | 5.5M | 6.7M |
| End Cash Position | 3.2M | 4.2M | 3.0M | 5.1M | 5.5M |
| Free Cash Flow | -390,984 | -201,166 | -117,719 | -365,425 | -344,357 |
| Asset Impairment Charge | -- | 0.00 | -- | -- | 0.00 |
| Change In Account Payable | -- | -- | -- | -31,814 | -- |
| Change In Prepaid Assets | -21,476 | 22,068 | 124,747 | -96,767 | 43,285 |
| Common Stock Issuance | -- | -- | -- | -- | 0.00 |
| Depreciation | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Losses From Equity Investments | -- | 0.00 | -- | -- | 22,371 |
| Gain Loss On Sale Of Business | -- | -- | -- | 0.00 | 0.00 |
| Gain Loss On Sale Of PPE | -- | 0.00 | 0.00 | 0.00 | 48,000 |
| Net Business Purchase And Sale | -- | -- | -- | -- | 0.00 |
| Net Foreign Currency Exchange Gain Loss | -444.00 | -22,360 | -12,400 | 0.00 | -- |
| Net Income From Continuing Operations | 18.5M | 1.4M | -1.5M | -5.9M | -749,270 |
| Net Other Investing Changes | -- | 0.00 | -- | -- | -- |
| Operating Gains Losses | -444.00 | -22,360 | -- | -- | 70,371 |
| Other Cash Adjustment Outside Changein Cash | -- | -- | -- | -- | 0.00 |
| Sale Of PPE | -- | 0.00 | 0.00 | 0.00 | 132,409 |
| Unrealized Gain Loss On Investment Securities | -18.8M | -1.6M | 1.3M | 5.6M | 340,578 |